Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer
A A Miller, E A Tolley, H B Niell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials
C L Bennett, T J Smith, S L George, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
June 15, 1999
Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer
K T Robbins, F S Wong, P Kumar, et al.
Archives of Internal Medicine
|
October 1, 1983
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer
H B Niell, G M Palmieri, C L Neely, et al.
Clinical Lung Cancer
|
January 1, 2004
Carboplatin/etoposide/paclitaxel in the treatment of patients with extensive small-cell lung cancer
H B Niell, M C Perry, G Clamon, et al.
Journal of Clinical Microbiology
|
June 1, 1987
Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome
L L Pifer, H B Niell, S B Langdon, et al.
Cancer
|
May 1, 1984
Incidence of Pneumocystis carinii antigenemia in ambulatory cancer patients
N J Robert, L L Pifer, H B Niell, et al.
Journal of Clinical Microbiology
|
November 1, 1984
Pneumocystis carinii antigenemia in adults with malignancy, infection, or pulmonary disease
L L Pifer, H B Niell, B J Morrison, et al.
Southern Medical Journal
|
November 1, 1983
Use of tumor colony assay in clinical oncology
H B Niell, C L Neely, C A Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2005
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
M A Socinski, A Ivanova, K Bakri, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer
A A Miller, E A Tolley, H B Niell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials
C L Bennett, T J Smith, S L George, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
June 15, 1999
Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer
K T Robbins, F S Wong, P Kumar, et al.
Archives of Internal Medicine
|
October 1, 1983
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer
H B Niell, G M Palmieri, C L Neely, et al.
Clinical Lung Cancer
|
January 1, 2004
Carboplatin/etoposide/paclitaxel in the treatment of patients with extensive small-cell lung cancer
H B Niell, M C Perry, G Clamon, et al.
Journal of Clinical Microbiology
|
June 1, 1987
Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome
L L Pifer, H B Niell, S B Langdon, et al.
Cancer
|
May 1, 1984
Incidence of Pneumocystis carinii antigenemia in ambulatory cancer patients
N J Robert, L L Pifer, H B Niell, et al.
Journal of Clinical Microbiology
|
November 1, 1984
Pneumocystis carinii antigenemia in adults with malignancy, infection, or pulmonary disease
L L Pifer, H B Niell, B J Morrison, et al.
Southern Medical Journal
|
November 1, 1983
Use of tumor colony assay in clinical oncology
H B Niell, C L Neely, C A Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2005
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
M A Socinski, A Ivanova, K Bakri, et al.
Page
of 5